GLP-1RA users had a 37% lower risk of developing dementia compared to those on other antidiabetic drugs. Stroke risk reduced ...

Semaglutide, marketed under the brand names Ozempic (for diabetes) and Wegovy (for weight loss), and tirzepatide, marketed as Mounjaro (for diabetes) and Zepbound (for weight loss), have proven to be ...